Home
overview

SMi's premier 10th Annual Parallel Trade for Pharma returns to London on 8-9 Feb 2016 after 9 successful years in the running!

Parallel distribution market in 2015 has been an interesting year: foreign exchange fluctuations, Greek crisis, tightened export control, legal battles on trademarks and counterfeit medicines. These, in addition to many other factors, have shifted the European market dynamics significantly.

Market participants continue to innovate new strategies to ensure revenue stream, but more importantly compliant of safety and accessibility of drugs for patients. The pressure of uncertainty is prompting industry colleagues to rethink and reassess their current supply chain models.
 

What new opportunities will present to parallel distribution in 2016? How should pharma and manufacturers perfect their sales and supply chain forecast? Will the EU Falsified Medicine Directive in 2018 reassure patient safety?

This is the only industry meeting with 80+ selected senior leaders in parallel trade to discuss upcoming trends and share best practices. Join us today to keep abreast and stay ahead of competition!

This conference will enable you to:

  • Update on parallel trade regulations to ensure compliance
  • Recap on regional markets' parallel trade activities and outlooks
  • Reassess and benchmark your supply chain and distribution model against peers' for best practice
  • Understand the rationale and strategy of parallel distributors through case studies and panel discussions
  • Network and interact with senior thought leaders to discuss common challenges and share experiences

 


 

Advisory Board 2016:
Eric Noehrenberg, Director, Regional Market Access Lead, Latin America, Shire International GmbH
Janice Haigh, Practice Leader, Market Access, Quintiles
Dr. Shabnam Hanassab, Senior Consultant, IMS Health

Who Should Attend?

VPs, Directors, Heads, Chiefs, Principals, Managers of:

  • Parallel Trade/ Import/ Export
  • Distribution
  • Supply Chain Management/ Planning
  • General Counsel
  • Legal
  • Market Access
  • Business Planning
  • Pricing
  • Finance
  • Procurement
  • Sales
  • Regulatory/ Public Affairs

from pharmaceutical and biotechs, drug manufacturers, pharmaceutical wholesalers, pharmacies, pharmaceutical importers and exporters, parallel traders, medical device, regulator and academics.

 

Abbott Laboratories Limited; Agency for Medicinal Products and Medical Devices of the Republic of Slovenia; Allergan Limited; Amgen; Amgen; Arnold and Porter; Astellas Pharma Europe; AstraZeneca; Bayer Healthcare; Biogen Idec; Biopharm Insight; Boehringer-Ingelheim; Bulmar ML Ltd; Chiesi Farmaceutici SpA; Delfarma; EY; Europe Economics; European Alliance for Access to Safe Medicines; European Association of Euro-Pharmaceutical Companies; Galderma; German Pharmaceutical Industry Association; Gilead Sciences Ltd; Grunenthal Gmbh; IGES Institut.; IMS Health; Kantar Health; LEO Pharma A/S; McKesson Global Procurement & Sourcing Limited; McKesson Pharmaceutical; MD Pharma SA; Merck Sharp and Dohme Israel; MHRA; MPA Business Services Ltd; MPCC Global Regulatory Solutions; Mundipharma ;NOVARTIS; Novo Nordisk Pharma AG; Otsuka Pharmaceutical Europe Ltd; Preglem/ Gedeon Richter; Quintiles (UK) Ltd; Ratiopharm GmbH; Sanofi Pasteur MSD; Shire Pharmaceuticals Group Plc; Smith & Nephew; Teva Pharmaceuticals Europe BV; The National Pharmaceutical Association Ltd; UCB Pharma and many more!

Conference programme

9:30 Registration & Coffee

10:00 Chairman's Opening Remarks

Eric Noehrenberg

Eric Noehrenberg Director, Regional Market Access Lead, Latin America, Shire International GmbH

10:10 OPENING ADDRESS: Chairman’s Introduction to Parallel Trade

Eric Noehrenberg

Eric Noehrenberg Director, Regional Market Access Lead, Latin America, Shire International GmbH

  • What is parallel trade?
  • Who benefits from parallel trade? What are the negative impacts of parallel trade?
  • Key players in parallel trade and their respective strategies?
  • Meeting the challenges of parallel trade
  • 10:50 PT in Germany - Situation and Perspective

    Bertram Häussler

    Bertram Häussler CEO, IGES Institut.

     

  • Importation dynamics
  • AMNOG and parallel trade
  • Future political and regulatory environment in Germany
  • 11:30 Morning Coffee & Networking Break

    12:00 Parallel Distribution - A View from the Top

    Heinz Kobelt

    Heinz Kobelt Director European Affairs, European Association of Euro-Pharmaceutical Companies

  • How parallel distribution integrates into the coming medicine verification system

  • The role of the EAEPC on current supply chain safety issues

  • 12:40 The Nordic Scene: Rise of Pharmacies and Wholesalers in PT

    Sigve Sivertsen

    Sigve Sivertsen Head of Parallel Trade, Apotek Hjärtat AB

  • Should this be a competition? Manufacturer vs. wholesaler vs. pharmacy in trade
  • Post-oil prices crisis with weakened kroners vs. purchasing patterns
  • Channel strategy to manage pharmaceutical product distribution
  • 13:20 Networking Lunch

    14:30 European Parallel Trade: Past, Present and Future

    Shabnam Hanassab

    Shabnam Hanassab Senior Consultant, IMS Health

  • Key trends and dynamics in distribution and dispensing
  • Outlook and key factors likely to influence the market going forward
  • 15:10 The Importance of External Reference Pricing in the Market Access – A Case from CEE Settings

    Katarzyna Kolasa

    Katarzyna Kolasa Former Market Access Director Region East; Adjunct Professor, Lundbeck; Collegium Medicum, Health Economics Dept, Bydgoszcz Poland

  • What is the impact of the reference pricing on reimbursement decisions
  • How to develop innovative pricing solution to secure the access to pharmaceuticals in CEE region
  • Why parallel trade can hurt search for the innovative pricing solution
  • 15:50 Afternoon Tea & Networking Break

    16:20 The Case Against Parallel Trade in the EU

    Dermot Glynn

    Dermot Glynn Senior Advisor, Europe Economics

  • Patented pharmaceuticals are not like widgets
  • Parallel trade is wasteful and does no good
  • Parallel trade prevents poor people from being treated with the best medicines
  • 17:00 PANEL DISCUSSION: Understanding the Rationale Behind

    Eric Noehrenberg

    Eric Noehrenberg Director, Regional Market Access Lead, Latin America, Shire International GmbH

    Dermot Glynn

    Dermot Glynn Senior Advisor, Europe Economics

  • The never-ending debate: Should medicinal products and devices be treated the same as other commodities?
  • The role played by parallel distributors on fairer prices and competitions
  • Harmonising national and European regulatory frameworks
  • Recap of the day and hot topics discussion
  • 17:30 Chairman's Closing Remarks and Close of Day One

    8:30 Registration & Coffee

    9:00 Chairman's Opening Remarks

    Eric Noehrenberg

    Eric Noehrenberg Director, Regional Market Access Lead, Latin America, Shire International GmbH

    9:10 Are You Ready? Implementation of Falsified Medicines Directive and Implications on Parallel Trade

    Gordon Cox

    Gordon Cox Operations Director, Alliance Healthcare Distribution Ltd.

  • Deadline of 2018 - are you on the right track and preparing for implementation?
  • Latest updates and requirements from regulators
  • Challenges of compliance for small- and mid-sized companies
  • Clear benefit of improving patient safety and combating counterfeited medicines from parallel trade
  • 9:50 Antitrust in the Pharmaceutical Sector: An overview of recent developments in the EU

    Werner Berg

    Werner Berg Partner, Baker & Mckenzie

  • Parallel trade - key issues and EU law
  • Enforcement overview regarding pharma distribution
  • Options for pharmaceutical companies
  • 10:30 Morning Coffee

    11:00 Antitrust in the Pharmaceutical Sector: The UK Perspective

    George  Lusty

    George Lusty Project Director, Enforcement Directorate, CMA

  • Explanation of the role of the CMA
  • Discussion of antitrust cases in the sector - such as Napp, Genzyme, Gaviscon, AstraZeneca, Servier and Lundbeck
  • Discussion of issues around excessive pricing (including phenytoin)
  • 11:40 Parallel Trade and Distribution in Denmark

    Mette Fjelsted

    Mette Fjelsted Head of Section, Media, Telecoms & Health Division, Danish Competition and Consumer Authority

  • The role of the DCCA
  • Regulatory environment for parallel trade in Denmark
  • Importance of parallel trade and some competition issues
  • 12:20 Intellectual Property Update

    Kathy Osgerby

    Kathy Osgerby Associate, Intellectual Property, Arnold & Porter

  • Refresher course on IP and parallel trade
  • Brand names in parallel trade - when is rebranding and repackaging allowed?
  • Patents in parallel trade - how does the specific mechanisms work?
  • Practical implications
  • 13:00 Networking Lunch

    14:00 A Macro View – Product Range vs. Product Value for Parallel Trade in Europe

    Vladimir Zah

    Vladimir Zah CEE Executive Committee Chair 2015-17, ISPOR

  • The increasingly diversified product portfolio for parallel distribution: What are upcoming?
  • Which categories of products are favored by parallel distributors?
  • 14:40 The Community Pharmacy Perspective

    Noel Wicks

    Noel Wicks Managing Director, Right Medicine Pharmacy

  • Parallel trade - the pharmacist perspective
  • Cost efficiency for NHS and distribution network
  • Online pharmacy and product authentication
  • 15:20 Recap of the 2016 Meeting – Ask the Panel and Audience

    Eric Noehrenberg

    Eric Noehrenberg Director, Regional Market Access Lead, Latin America, Shire International GmbH

    Delegates will have the final chance to ask speakers and colleagues plus summing up what they’ve learnt over the 2-day meeting. It’ll be a recap for objectives set on Day 1 and sharing of key takeaways.

    15:45 Chairman’s Closing Remarks and Close of Day Two

    +

    FEATURED SPEAKERS

    Eric Noehrenberg

    Eric Noehrenberg

    Director, Regional Market Access Lead, Latin America, Shire International GmbH
    Shabnam Hanassab

    Shabnam Hanassab

    Senior Consultant, IMS Health
    Sigve Sivertsen

    Sigve Sivertsen

    Head of Parallel Trade, Apotek Hjärtat AB

    Bertram Häussler

    CEO, IGES Institut.
    Bertram Häussler

    Dermot Glynn

    Senior Advisor, Europe Economics
    Dermot Glynn

    Eric Noehrenberg

    Director, Regional Market Access Lead, Latin America, Shire International GmbH
    Eric Noehrenberg

    George Lusty

    Project Director, Enforcement Directorate, CMA
    George  Lusty

    Gordon Cox

    Operations Director, Alliance Healthcare Distribution Ltd.
    Gordon Cox

    Heinz Kobelt

    Director European Affairs, European Association of Euro-Pharmaceutical Companies
    Heinz Kobelt

    Janice Haigh

    European Price & Trade Director,
    Janice Haigh

    Katarzyna Kolasa

    Former Market Access Director Region East; Adjunct Professor, Lundbeck; Collegium Medicum, Health Economics Dept, Bydgoszcz Poland
    Katarzyna Kolasa

    Kathy Osgerby

    Associate, Intellectual Property, Arnold & Porter
    Kathy Osgerby

    Maarten Kamphuis

    Managing Director Pharmachim, Business Development, FisherFarma
    Maarten Kamphuis

    Mette Fjelsted

    Head of Section, Media, Telecoms & Health Division, Danish Competition and Consumer Authority
    Mette Fjelsted

    Noel Wicks

    Managing Director, Right Medicine Pharmacy
    Noel Wicks

    Shabnam Hanassab

    Senior Consultant, IMS Health
    Shabnam Hanassab

    Sigve Sivertsen

    Head of Parallel Trade, Apotek Hjärtat AB
    Sigve Sivertsen

    Vladimir Zah

    CEE Executive Committee Chair 2015-17, ISPOR
    Vladimir Zah

    Werner Berg

    Partner, Baker & Mckenzie
    Werner Berg

    Official Publication

    Supporters

    ASSOCIATED EVENTS

    Parallel Trade – Management Strategies
    Workshop

    Parallel Trade – Management Strategies

    Holiday Inn Kensington Forum
    10th February 2016
    London, United Kingdom

    Understanding Legal Issues Around Parallel Distribution
    Workshop

    Understanding Legal Issues Around Parallel Distribution

    Holiday Inn Kensington Forum
    10th February 2016
    London, United Kingdom

    VENUE

    Holiday Inn Kensington Forum

    97 Cromwell Road , London, United Kingdom

    Holiday Inn Kensington Forum is perfectly situated in one of London’s most luxurious and beautiful areas within South Kensington. 

    The hotel is just 2 minutes walk from Gloucester Road tube station for convenient travel to Hyde Park, London Eye, Tower Bridge plus more of London’s top attractions. There are also easy and direct links to some major transport hubs including Victoria, Kings Cross St Pancras, Paddington and Heathrow. 

    This distinctive hotel in south London has so much to offer to make all guests really feel at home. The latest Holiday Inn relaunch is not just about the new look and feel for the hotel but to offer guests more benefits during their stay including a pillow menu for extra comfort during their sleep and a curved shower rail for more spacious feel. 

    In addition to our 906 rooms, all business guests can take advantage of our meeting and conference facilities including High Speed Internet Access and unlimited Starbucks coffee at The Academy. Our hotel’s professional event planners are on board to help take the hard work and stress away from planning your next event. 

    So whether you in London on business or pleasure, make the Holiday Inn London Kensington Forum your first choice of hotel and book your accommodation for our lowest internet rate guarantee. 

    HOTEL BOOKING FORM

    Preliminary list of attendees

    Download

    Speaker Interview - Arty Rajendra, Partner, IP Litigation, Rouse

    Download

    Media Partners


    Int. J. of Biotechnology

    Official Publication
    http://www.inderscience.com/ijbt

    IJBT provides an international forum and refereed authoritative source of information in the field of Biotechnology and Biotechnics, with emphasis on management and economics, as well as the political and social issues. It aims to disseminate knowledge, provide a learned reference in the field, and establish channels of communication between academic and research experts, policy makers and executives in industry, commerce and investment institutions.


    International Journal of Biomedical Engineering and Technology

    Official Publication
    http://www.inderscience.com/ijbet

    IJBET addresses cutting-edge research in the multi-disciplinary area of biomedical engineering and technology. Medical science incorporates scientific/technological advances combining to produce more accurate diagnoses, effective treatments with fewer side effects, and improved ability to prevent disease and provide superior-quality healthcare. A key field here is biomedical engineering/technology, offering a synthesis of physical, chemical, mathematical and computational sciences combined with engineering principles to enhance R&D in biology, medicine, behaviour, and health. IJBET includes the Asia-Pacific Chapter in Biomedical Wireless Technology (APC-BWT).


    International Journal of Healthcare Policy

    Official Publication
    http://www.inderscience.com/ijhp

    IJHP serves as a forum for interdisciplinary discussion of leading issues in healthcare law, medicine and health policy. Emphasis is placed on issues such as legislative and regulatory environments, and plans and actions that are undertaken by organisations and agencies to achieve specific healthcare goals within society. This perspective is reflective of the broad range of efforts to advance the public's health.


    International Journal of Healthcare Technology and Management

    Official Publication
    http://www.inderscience.com/ijhtm

    IJHTM is a series emerging from the International Journal of Technology Management. It provides an international forum and refereed authoritative sources of information in the fields of the economics and management of technology in healthcare.


    International Journal of Technology, Policy and Management

    Official Publication
    http://www.inderscience.com/ijtpm

    IJTPM is a refereed international journal that provides a professional and scholarly forum in the emerging field of decision making and problem solving in the integrated area of technology policy and management at the operational, organisational and public policy levels.


    Absave

    Supporters
    http://www.absave.com

    Absave.com is the leading savings website for Antibodies and Immunological Products. Search our extensive database of Antibodies, Kits, Proteins & Peptides, Reagents, etc. to find the best savings!


    Antibodies Online

    Supporters
    http://www.antibodies-online.com

    antibodies-online.com facilitates researchers to find the appropriate antibodies for their respective research project. As an independent and multi-vendor marketplace for research antibodies and thanks to the cooperation with more than 130 different manufacturers, a large selection of Antibodies (over 700,000), ELISA Kits (over 130,000), Secondary Antibodies (17,000), Proteins (130,000), Peptides and Isotype Controls is available. By supporting the Independent Validation Initiative and the Resource Identification Initiative, antibodies-online.com also addresses the important topics of transparent product quality and scientific reproducibility. In addition scientists receive news and detailed information about the individual antibodies from databases such as the PubMed and others.


    Biocompare

    Supporters
    http://www.biocompare.com

    Biocompare is the most comprehensive, in-depth, and objective website for life science product information. Thousands of scientists use Biocompare daily to quickly find the right product for their experiments rather than looking through multiple print catalogs. Visit Biocompare to find the products you need, stay informed of new technologies, read product reviews, watch product videos, and keep up-to-date on life science news. Visit: www.biocompare.com


    Bioscreening

    Supporters
    http://www.bioscreening.com



    British Pharmacological Society

    Supporters
    http://www.bps.ac.uk

    The British Pharmacological Society (BPS) is the primary UK learned society concerned with research into drugs and the way they work. Our members work in academia, industry, regulatory agencies and the health services, and many are medically qualified. The Society covers the whole spectrum of pharmacology, including laboratory, clinical, and toxicological aspects. Clinical pharmacology is the medical speciality dedicated to promoting safe and effective use of medicines for patient benefit. Clinical pharmacologists work as consultants in the NHS and many hold prominent positions in UK Universities.


    Drug Development Technology

    Supporters
    http://www.drugdevelopment-technology.com

    Drugdevelopment-technology.com covers every aspect of the drug development and research process, from conception to pre-FDA approval. Our global network of journalists updates the site with the latest and most significant industry developments. This coverage allows us to provide everyone - from senior management through to research and QA staff – with in-depth reviews of the latest projects, advance notice of new product releases and analysis of the latest procedural and legislative developments.


    Drug Discovery Today

    Supporters
    http://www.drugdiscoverytoday.com/

    Drug Discovery Today is one of the most cited review journals in the field of drug discovery, with an impact factor of 6.422.
    Drug Discovery Today will benefit your research by helping to keep you up-to-date with all of the fast-moving and emerging topics in drug discovery. Each issue is packed full of the latest research news, peer-reviewed articles and comment and opinion from leading research scientists.


    Drug Discovery World

    Supporters
    http://www.ddw-online.com

    For over a decade DDW has continued to be the ‘must read’ journal within the DD&D Arena. DDW is recognised for voicing the opinions of some of the Industry’s leading luminaries and has become a recognised platform for Industry Gurus to debate some of the more challenging technological and business issues facing the the life science industry. DDW adheres to the maxim..... ‘Turning Science into Business’ DDW examines the advances in new technologies and the associated implications within the context of developing new and efficacious therapeutics. DDW is distinguishable in that it reaches out to a global audience at both bench and boardroom level, allowing both camps to profit from the uncomplicated style of editorial but at the same time challenges our readers to look at new ways to overcome discovery bottlenecks, embrace nascent technologies and build next generation technology platforms.


    European Pharmaceutical Contractor

    Supporters
    http://www.samedanltd.com/magazine/11

    European Pharmaceutical Contractor (EPC) is a quarterly publication dedicated to the international pharmaceutical contract market. Since its establishment in 1997, EPC has provided coverage of technical, strategic and regulatory developments within the industry. The magazine features in-depth opinion-led articles, reviews and interviews, on topics including drug development, outsourcing, pharmacovigilance, partnerships and eClinical management. Read EPC in print, online, or via the Samedan app.


    Farmavita

    Supporters
    http://www.farmavita.net/

    Farmavita Net is professional community and network of pharmaceutical licensing and business development executives, innovators and researchers
    Farmavita.Net is the pharmaceutical licensing, technology transfer and regulatory affairs network. We are managing the marketplace of offers and demand for pharmaceutical Dossiers, know-how and technologies. Members of Farmavita.Net network usually find a number of attractive solutions for business development, alliances, joint ventures, co-development and co-marketing of pharmaceutical products. Farmavita.Net is not just a pure Internet portal. We manage a number of regional associates. We are connecting the dynamic network of few hundreds members / pharmaceutical companies interested in license-in and license-out opportunities.


    Frontiers in Clinical Drug Research - Anti-Cancer Agents

    Supporters
    http://ebooks.benthamscience.com/book/9781681080727/

    Frontiers in Clinical Drug Research - Anti-Cancer Agents should prove to be a valuable resource for pharmaceutical scientists and postgraduate students seeking updated and critical information for developing clinical trials and devising research plans in the field. The chapters featured in each volume are written by leading experts in oncology and clinical pharmacology. The eBook series is essential reading for all scientists involved in clinical drug research who wish to keep abreast of rapid and important developments in the development of anti-cancer agents.The contents of this volume include reviews on dendrimers for anti-cancer drug delivery, treatment methods for advanced cutaneous squamous cell carcinoma, targeting heat shock proteins for cancer treatment, Bayesian systems for optimizing treatment protocols in oncology and much more.


    Gate2Biotech

    Supporters
    http://www.gate2biotech.com

    Gate2Biotech is a portal that unites biotechnological community in Central Europe. It covers all the news in the field of biotechnology. Thanks to the the portal the companies engaged in the field can easily search for research institutions and other partners to solve technical problems they are facing and here they can also present their services offer to potential partners from the Czech Republic and abroad. Gate2Biotech portal serves as a bridge connecting scientific and commercial sector. It incorporates offices and support organizations dedicated to promoting transfer of innovative technologies into a unified communication platform of Czech and international biotechnologies. As a mediator of information it draws attention to biotechnologies and support of their application and transfer into practice. It also functions as a tool for encouraging non-professionals (especially scientists and students) towards innovative business or applied research.


    Inderscience Publishers

    Supporters
    http://www.inderscience.com

    Inderscience is a dynamic, leading, independent journal publisher. The company disseminates the latest research across the broad fields of science, engineering and technology; management, public and business administration; environment, ecological economics and sustainable development; computing, ICT and internet/web services, and related areas. Inderscience offers over 35 years' experience in publishing and has succeeded in building a substantial collection approaching 400 high-quality peer-reviewed international research journals in both online and print formats. We offer a variety of ways to keep up-to-date with the latest published leading-edge research while our online collection represents a fully-searchable digital archive of around 60,000 articles.


    Labsave

    Supporters
    http://www.labsave.com

    Labsave is the leading savings website for Laboratory Equipment and Lab Supplies. We work closely with the top suppliers in the world to bring you the best products at the most competitive prices. We are constantly striving to secure the biggest and most exclusive offers that you won’t find anywhere else! http://www.labsave.com/


    Mednous

    Supporters
    http://www.MedNous.com

    MedNous is a print publication and website about medical innovation in Europe. It carries exclusive interviews with companies that are at the forefront of medical technology, as well as contributor articles from prominent practitioners. Our mission is to identify significant advances in medicine and to explain how this innovation is being commercialised. In doing so, we talk to venture capitalists about what products and platforms they are supporting. We report on how regulators cope with the accelerating pace of innovation. And we regularly cover the latest developments in the discovery and development of new medical concepts in the area of antibodies, vaccines, small molecules, regenerative medicine and nanomedicines. MedNous combines the English word for medicine with the Greek word for intellect. And those with nous are readers of our publication. Visit our website: www.mednous.com


    One Nucleus

    Supporters
    http://www.onenucleus.com

    Established in May 2010, One Nucleus is the result of the merger of ERBI and London Biotechnology Network. One Nucleus is a not-for-profit membership organisation for international life science and healthcare companies and the largest of its kind in Europe. The company is based in Cambridge UK and London, at the heart of Europe's largest cluster. The 470 members include pharmaceutical, biotech, medical device and diagnostic companies and associated technical and commercial Service Providers.


    PharmaVOICE

    Supporters
    http://www.pharmavoice.com

    PharmaVOICE magazine, and its supporting VIEW publications, provide commentary about the challenges and trends impacting the life-sciences industry, covering a range of issues from molecule through market. PharmaVOICE's more than 41,000 U.S.-based subscribers are also kept abreast of the latest trends through additional media resources, including WebSeminars, Podcasts, Videocasts, and White Papers.


    SelectScience

    Supporters
    http://www.selectscience.net/register?utm_source=Media-Partner&utm_medium=Website&utm_campaign=SMI

    SelectScience is an independent, online information resource for the worldwide scientific community, and the home of trusted information for laboratory scientists. Discover the latest drug discovery and development technologies, products and techniques with product reviews, videos, application notes and news articles. Become a member for free today.


    Swiss Biotech Association

    Supporters
    http://www.swissbiotech.org/

    The Swiss Biotech Association (SBA) is the national industry association for biotechnology, including pharmaceuticals, diagnostics, agriculture, food, cosmetics, environmental biotechnology, and specialty chemicals. Members are companies active in modern biotechnology, such as R&D, Production, Marketing and Sales, Finance, Services and Consulting. SBA provides a networking platform for Life Science clusters, academic and federal institutions the like. Founded in March 1998, the Association grows steadily.


    Technology Networks

    Supporters
    http://www.technologynetworks.com

    Founded in 2000, Technology Networks is established as the leading news provider for life science and drug discovery professionals. In addition, we provide unique content including webcasts, videos, application notes and posters from recent conferences. Our portfolio now includes around 30 focussed scientific communities, all of which are accessible free of charge within TechnologyNetworks.com

    SAVE TO


    Outlook Calendar  OUTLOOK CALENDAR
    Google Calendar  GOOGLE CALENDAR
    ICal Calendar  ICAL CALENDAR
    Yahoo! Calendar  YAHOO! CALENDAR

    Holiday Inn Kensington Forum

    97 Cromwell Road
    London SW7 4DN
    United Kingdom

    Holiday Inn Kensington Forum

    Holiday Inn Kensington Forum is perfectly situated in one of London’s most luxurious and beautiful areas within South Kensington. 

    The hotel is just 2 minutes walk from Gloucester Road tube station for convenient travel to Hyde Park, London Eye, Tower Bridge plus more of London’s top attractions. There are also easy and direct links to some major transport hubs including Victoria, Kings Cross St Pancras, Paddington and Heathrow. 

    This distinctive hotel in south London has so much to offer to make all guests really feel at home. The latest Holiday Inn relaunch is not just about the new look and feel for the hotel but to offer guests more benefits during their stay including a pillow menu for extra comfort during their sleep and a curved shower rail for more spacious feel. 

    In addition to our 906 rooms, all business guests can take advantage of our meeting and conference facilities including High Speed Internet Access and unlimited Starbucks coffee at The Academy. Our hotel’s professional event planners are on board to help take the hard work and stress away from planning your next event. 

    So whether you in London on business or pleasure, make the Holiday Inn London Kensington Forum your first choice of hotel and book your accommodation for our lowest internet rate guarantee. 

    HOTEL BOOKING FORM

    Title

    SubTitle
    speaker image

    Content


    Title


    Description

    Download


    WHAT IS CPD?

    CPD stands for Continuing Professional Development’. It is essentially a philosophy, which maintains that in order to be effective, learning should be organised and structured. The most common definition is:

    ‘A commitment to structured skills and knowledge enhancement for Personal or Professional competence’

    CPD is a common requirement of individual membership with professional bodies and Institutes. Increasingly, employers also expect their staff to undertake regular CPD activities.

    Undertaken over a period of time, CPD ensures that educational qualifications do not become obsolete, and allows for best practice and professional standards to be upheld.

    CPD can be undertaken through a variety of learning activities including instructor led training courses, seminars and conferences, e:learning modules or structured reading.

    CPD AND PROFESSIONAL INSTITUTES

    There are approximately 470 institutes in the UK across all industry sectors, with a collective membership of circa 4 million professionals, and they all expect their members to undertake CPD.

    For some institutes undertaking CPD is mandatory e.g. accountancy and law, and linked to a licence to practice, for others it’s obligatory. By ensuring that their members undertake CPD, the professional bodies seek to ensure that professional standards, legislative awareness and ethical practices are maintained.

    CPD Schemes often run over the period of a year and the institutes generally provide online tools for their members to record and reflect on their CPD activities.

    TYPICAL CPD SCHEMES AND RECORDING OF CPD (CPD points and hours)

    Professional bodies and Institutes CPD schemes are either structured as ‘Input’ or ‘Output’ based.

    ‘Input’ based schemes list a precise number of CPD hours that individuals must achieve within a given time period. These schemes can also use different ‘currencies’ such as points, merits, units or credits, where an individual must accumulate the number required. These currencies are usually based on time i.e. 1 CPD point = 1 hour of learning.

    ‘Output’ based schemes are learner centred. They require individuals to set learning goals that align to professional competencies, or personal development objectives. These schemes also list different ways to achieve the learning goals e.g. training courses, seminars or e:learning, which enables an individual to complete their CPD through their preferred mode of learning.

    The majority of Input and Output based schemes actively encourage individuals to seek appropriate CPD activities independently.

    As a formal provider of CPD certified activities, SMI Group can provide an indication of the learning benefit gained and the typical completion. However, it is ultimately the responsibility of the delegate to evaluate their learning, and record it correctly in line with their professional body’s or employers requirements.

    GLOBAL CPD

    Increasingly, international and emerging markets are ‘professionalising’ their workforces and looking to the UK to benchmark educational standards. The undertaking of CPD is now increasingly expected of any individual employed within today’s global marketplace.

    CPD Certificates

    We can provide a certificate for all our accredited events. To request a CPD certificate for a conference , workshop, master classes you have attended please email events@smi-online.co.uk

    Event Title

    Headline

    Text
    Read More

    I would like to speak at an event

    I would like to attend an event

    I would like to sponsor/exhibit at an event

    SIGN UP OR LOGIN

    Sign up
    Forgotten Password?

    Contact SMi GROUP LTD

    UK Office
    Opening Hours: 9.00 - 17.30 (local time)
    SMi Group Ltd, 2nd Floor South, Harling House, 47-51 Great Suffolk Street, London, SE1 0BS, United Kingdom, Link to Map
    Tel: +44 (0) 20 7827 6000 Fax: +44 (0) 20 7827 6001
    Website: http://www.smi-online.co.uk Email: events@smi-online.co.uk
    Registered in England No: 3779287 VAT No: GB 976 2951 71




    Forgotten Password

    Please enter the email address you registered with. We will email you a new password.